2025-04-01 2026-03-31 false Capium Accounts Production 1.1 09848147 2025-04-01 2026-03-31 09848147 bus:AbridgedAccounts 2025-04-01 2026-03-31 09848147 bus:Micro-entities 2025-04-01 2026-03-31 09848147 bus:AuditExempt-NoAccountantsReport 2025-04-01 2026-03-31 09848147 bus:SmallCompaniesRegimeForAccounts 2025-04-01 2026-03-31 09848147 bus:PrivateLimitedCompanyLtd 2025-04-01 2026-03-31 09848147 2025-04-01 2026-03-31 09848147 2026-03-31 09848147 bus:RegisteredOffice 2025-04-01 2026-03-31 09848147 core:WithinOneYear 2026-03-31 09848147 core:AfterOneYear 2026-03-31 09848147 1 2025-04-01 2026-03-31 09848147 bus:Director1 2025-04-01 2026-03-31 09848147 bus:Director1 2026-03-31 09848147 bus:Director1 2024-04-01 2025-03-31 09848147 2024-04-01 09848147 bus:CompanySecretary1 2025-04-01 2026-03-31 09848147 bus:LeadAgentIfApplicable 2025-04-01 2026-03-31 09848147 2024-04-01 2025-03-31 09848147 2025-03-31 09848147 core:WithinOneYear 2025-03-31 09848147 core:AfterOneYear 2025-03-31 09848147 bus:EntityAccountantsOrAuditors 2024-04-01 2025-03-31 09848147 core:PlantMachinery 2025-04-01 2026-03-31 09848147 core:PlantMachinery 2026-03-31 09848147 core:PlantMachinery 2025-03-31 09848147 core:ComputerEquipment 2025-04-01 2026-03-31 09848147 core:ComputerEquipment 2026-03-31 09848147 core:ComputerEquipment 2025-03-31 09848147 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2026-03-31 09848147 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2025-03-31 09848147 core:CostValuation core:Non-currentFinancialInstruments 2026-03-31 09848147 core:CostValuation core:Non-currentFinancialInstruments 2025-03-31 09848147 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2026-03-31 09848147 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2026-03-31 09848147 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2026-03-31 09848147 core:Non-currentFinancialInstruments 2026-03-31 09848147 core:Non-currentFinancialInstruments 2025-03-31 iso4217:GBP xbrli:shares xbrli:pure
Reports Dated : 10/06/2026 Registered Number: 09848147
England and Wales

 

 

 

HAK PHARM LTD



Abridged Accounts
 


Period of accounts

Start date: 01 April 2025

End date: 31 March 2026
  2026   2025
    £ £   £ £
Fixed assets   628      1,261 
Current assets 14,218      15,081   
Creditors: amount falling due within one year (19,336)     (15,435)  
Net current assets   (5,118)     (354)
Total assets less current liabilities   (4,490)     907 
Creditors: amount falling due after more than one year       (600)
Net assets   (4,490)     307 
 

         
Capital and reserves   (4,490)     306 
 
NOTES TO THE ACCOUNTS

General Information
HAK PHARM LTD is a private company, limited by shares, registered in England and Wales, registration number 09848147, registration address 37 Burnsdale, Allerton, Bradford, West Yorkshire, BD15 9DA.

The presentation currency is £ sterling.
1.

Accounting policies

Significant accounting policies
Statement of compliance
These financial statements have been prepared in compliance with FRS 105 – The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006.
Basis of preparation
The financial statements have been prepared under the historical cost convention.
The financial statements are prepared in sterling which is the functional currency of the company.
2.

Average number of employees

Average number of employees during the year was 2 (2025 : 2).


For the year ended 31 March 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's Responsibilities:
The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.

The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.

These accounts have been prepared in accordance with the micro-entity provisions and FRS 105, the Financial Reporting Standard applicable to the micro-entities regime. The accounts have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. The income statement has not been delivered to the Registrar of Companies.

The members have agreed to the preparation of abridged accounts.
The financial statements were approved by the director on 08 May 2026 and were signed by:


--------------------------------
Haider Ahmed Khan
Director
1